Report Detail
Global Acetazolamide Market Insights, Forecast to 2025
- RnM3518058 |
- 12 June, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Acetazolamide, sold under the trade name Diamox among others, is a medication used to treat glaucoma, epilepsy, altitude sickness, periodic paralysis, idiopathic intracranial hypertension, and heart failure. It may be used long term for the treatment of open angle glaucoma and short term for acute angle closure glaucoma until surgery can be carried out. It is taken by mouth or injection into a vein.
The global Acetazolamide market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Acetazolamide market based on company, product type, end user and key regions.
This report studies the global market size of Acetazolamide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Acetazolamide in these regions.
This research report categorizes the global Acetazolamide market by top players/brands, region, type and end user. This report also studies the global Acetazolamide market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Teva
TARO
Zydus Pharmaceuticals
Lannett Company
Sun Pharmaceutical
Heritage Pharmaceuticals
Nostrum Laboratories
Accord Healthcare
Strides Pharma
West-Ward Pharmaceuticals
X-Gen Pharmaceuticals
Mylan
Emcure
Market size by Product
Tablets
Capsule
Injection
Market size by End User
Hospital
Drug store
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Acetazolamide market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Acetazolamide market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Acetazolamide companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Acetazolamide submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Acetazolamide are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Acetazolamide market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Acetazolamide Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Acetazolamide Market Size Growth Rate by Product
- 1.4.2 Tablets
- 1.4.3 Capsule
- 1.4.4 Injection
- 1.5 Market by End User
- 1.5.1 Global Acetazolamide Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Drug store
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Acetazolamide Market Size
- 2.1.1 Global Acetazolamide Revenue 2014-2025
- 2.1.2 Global Acetazolamide Sales 2014-2025
- 2.2 Acetazolamide Growth Rate by Regions
- 2.2.1 Global Acetazolamide Sales by Regions
- 2.2.2 Global Acetazolamide Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Acetazolamide Sales by Manufacturers
- 3.1.1 Acetazolamide Sales by Manufacturers
- 3.1.2 Acetazolamide Sales Market Share by Manufacturers
- 3.1.3 Global Acetazolamide Market Concentration Ratio (CR5 and HHI)
- 3.2 Acetazolamide Revenue by Manufacturers
- 3.2.1 Acetazolamide Revenue by Manufacturers (2014-2019)
- 3.2.2 Acetazolamide Revenue Share by Manufacturers (2014-2019)
- 3.3 Acetazolamide Price by Manufacturers
- 3.4 Acetazolamide Manufacturing Base Distribution, Product Types
- 3.4.1 Acetazolamide Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Acetazolamide Product Type
- 3.4.3 Date of International Manufacturers Enter into Acetazolamide Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Acetazolamide Sales by Product
- 4.2 Global Acetazolamide Revenue by Product
- 4.3 Acetazolamide Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Acetazolamide Breakdown Data by End User
6 North America
- 6.1 North America Acetazolamide by Countries
- 6.1.1 North America Acetazolamide Sales by Countries
- 6.1.2 North America Acetazolamide Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Acetazolamide by Product
- 6.3 North America Acetazolamide by End User
7 Europe
- 7.1 Europe Acetazolamide by Countries
- 7.1.1 Europe Acetazolamide Sales by Countries
- 7.1.2 Europe Acetazolamide Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Acetazolamide by Product
- 7.3 Europe Acetazolamide by End User
8 Asia Pacific
- 8.1 Asia Pacific Acetazolamide by Countries
- 8.1.1 Asia Pacific Acetazolamide Sales by Countries
- 8.1.2 Asia Pacific Acetazolamide Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Acetazolamide by Product
- 8.3 Asia Pacific Acetazolamide by End User
9 Central & South America
- 9.1 Central & South America Acetazolamide by Countries
- 9.1.1 Central & South America Acetazolamide Sales by Countries
- 9.1.2 Central & South America Acetazolamide Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Acetazolamide by Product
- 9.3 Central & South America Acetazolamide by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Acetazolamide by Countries
- 10.1.1 Middle East and Africa Acetazolamide Sales by Countries
- 10.1.2 Middle East and Africa Acetazolamide Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Acetazolamide by Product
- 10.3 Middle East and Africa Acetazolamide by End User
11 Company Profiles
- 11.1 Teva
- 11.1.1 Teva Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Teva Acetazolamide Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Teva Acetazolamide Products Offered
- 11.1.5 Teva Recent Development
- 11.2 TARO
- 11.2.1 TARO Company Details
- 11.2.2 Company Business Overview
- 11.2.3 TARO Acetazolamide Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 TARO Acetazolamide Products Offered
- 11.2.5 TARO Recent Development
- 11.3 Zydus Pharmaceuticals
- 11.3.1 Zydus Pharmaceuticals Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Zydus Pharmaceuticals Acetazolamide Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Zydus Pharmaceuticals Acetazolamide Products Offered
- 11.3.5 Zydus Pharmaceuticals Recent Development
- 11.4 Lannett Company
- 11.4.1 Lannett Company Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Lannett Company Acetazolamide Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Lannett Company Acetazolamide Products Offered
- 11.4.5 Lannett Company Recent Development
- 11.5 Sun Pharmaceutical
- 11.5.1 Sun Pharmaceutical Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Sun Pharmaceutical Acetazolamide Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Sun Pharmaceutical Acetazolamide Products Offered
- 11.5.5 Sun Pharmaceutical Recent Development
- 11.6 Heritage Pharmaceuticals
- 11.6.1 Heritage Pharmaceuticals Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Heritage Pharmaceuticals Acetazolamide Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Heritage Pharmaceuticals Acetazolamide Products Offered
- 11.6.5 Heritage Pharmaceuticals Recent Development
- 11.7 Nostrum Laboratories
- 11.7.1 Nostrum Laboratories Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Nostrum Laboratories Acetazolamide Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Nostrum Laboratories Acetazolamide Products Offered
- 11.7.5 Nostrum Laboratories Recent Development
- 11.8 Accord Healthcare
- 11.8.1 Accord Healthcare Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Accord Healthcare Acetazolamide Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Accord Healthcare Acetazolamide Products Offered
- 11.8.5 Accord Healthcare Recent Development
- 11.9 Strides Pharma
- 11.9.1 Strides Pharma Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Strides Pharma Acetazolamide Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Strides Pharma Acetazolamide Products Offered
- 11.9.5 Strides Pharma Recent Development
- 11.10 West-Ward Pharmaceuticals
- 11.10.1 West-Ward Pharmaceuticals Company Details
- 11.10.2 Company Business Overview
- 11.10.3 West-Ward Pharmaceuticals Acetazolamide Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 West-Ward Pharmaceuticals Acetazolamide Products Offered
- 11.10.5 West-Ward Pharmaceuticals Recent Development
- 11.11 X-Gen Pharmaceuticals
- 11.12 Mylan
- 11.13 Emcure
12 Future Forecast
- 12.1 Acetazolamide Market Forecast by Regions
- 12.1.1 Global Acetazolamide Sales Forecast by Regions 2019-2025
- 12.1.2 Global Acetazolamide Revenue Forecast by Regions 2019-2025
- 12.2 Acetazolamide Market Forecast by Product
- 12.2.1 Global Acetazolamide Sales Forecast by Product 2019-2025
- 12.2.2 Global Acetazolamide Revenue Forecast by Product 2019-2025
- 12.3 Acetazolamide Market Forecast by End User
- 12.4 North America Acetazolamide Forecast
- 12.5 Europe Acetazolamide Forecast
- 12.6 Asia Pacific Acetazolamide Forecast
- 12.7 Central & South America Acetazolamide Forecast
- 12.8 Middle East and Africa Acetazolamide Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Acetazolamide Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Acetazolamide . Industry analysis & Market Report on Acetazolamide is a syndicated market report, published as Global Acetazolamide Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Acetazolamide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
